IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.142
EU - Europa 4.435
AS - Asia 3.341
SA - Sud America 1.396
AF - Africa 100
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.027
SG - Singapore 1.405
BR - Brasile 1.229
IE - Irlanda 1.029
CN - Cina 1.026
SE - Svezia 1.026
IT - Italia 614
HK - Hong Kong 408
DE - Germania 407
UA - Ucraina 312
PL - Polonia 207
FI - Finlandia 206
VN - Vietnam 180
RU - Federazione Russa 168
GB - Regno Unito 163
FR - Francia 138
IN - India 82
AR - Argentina 61
CA - Canada 55
BE - Belgio 42
MX - Messico 39
ZA - Sudafrica 33
EC - Ecuador 29
BD - Bangladesh 28
JP - Giappone 28
NL - Olanda 27
TR - Turchia 24
IQ - Iraq 23
AT - Austria 20
ID - Indonesia 18
MA - Marocco 18
UZ - Uzbekistan 17
IR - Iran 16
VE - Venezuela 16
CZ - Repubblica Ceca 15
ES - Italia 14
CO - Colombia 13
EG - Egitto 13
UY - Uruguay 13
AL - Albania 10
AU - Australia 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
AZ - Azerbaigian 8
KE - Kenya 8
PK - Pakistan 8
TN - Tunisia 8
KZ - Kazakistan 7
LT - Lituania 7
BO - Bolivia 6
CI - Costa d'Avorio 6
JO - Giordania 6
KR - Corea 6
CL - Cile 5
DO - Repubblica Dominicana 5
GY - Guiana 5
JM - Giamaica 5
KH - Cambogia 5
OM - Oman 5
RO - Romania 5
AM - Armenia 4
LB - Libano 4
LU - Lussemburgo 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
NP - Nepal 3
SA - Arabia Saudita 3
SN - Senegal 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
ET - Etiopia 2
HN - Honduras 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
Totale 15.419
Salva come PNG Salva come JPEG
Città #
Dublin 1.029
Ashburn 800
Chandler 736
Singapore 719
Dallas 676
Jacksonville 644
Nyköping 513
Beijing 458
Hong Kong 407
Warsaw 197
Messina 187
Princeton 170
Boardman 162
Cambridge 157
Medford 153
Los Angeles 152
Dearborn 144
Ann Arbor 139
The Dalles 131
Des Moines 127
Munich 101
São Paulo 98
Buffalo 80
New York 66
Ho Chi Minh City 65
Jinan 57
Moscow 53
Woodbridge 53
Wilmington 44
Redondo Beach 42
Shenyang 40
Brussels 39
Hanoi 38
Belo Horizonte 36
Frankfurt am Main 36
Turku 35
Catania 34
San Mateo 33
Tianjin 32
Bremen 30
Zhengzhou 30
Rio de Janeiro 29
Hyderabad 28
Lancaster 28
Düsseldorf 26
Hebei 26
Porto Alegre 24
Brooklyn 23
Curitiba 23
Helsinki 23
Houston 23
Santa Clara 23
London 22
Seattle 22
Tokyo 22
Brasília 21
Ningbo 21
Montreal 20
Nanjing 19
Guangzhou 18
Rome 18
Stockholm 18
Chennai 17
Denver 17
Haikou 17
Johannesburg 17
Taizhou 17
Boston 16
Lauterbourg 16
Pune 16
Atlanta 15
Sorocaba 15
Dong Ket 14
Tashkent 14
Ottawa 13
Washington 13
Campinas 12
Council Bluffs 12
Fortaleza 12
Quito 12
Campo Grande 11
Hefei 11
Lanzhou 11
Norwalk 11
Baghdad 10
Columbus 10
Guarulhos 10
Jakarta 10
Montevideo 10
Nanchang 10
Recife 10
San Francisco 10
Santo André 10
Viagrande 10
Vienna 10
Betim 9
Caltagirone 9
Goiânia 9
Guayaquil 9
Hangzhou 9
Totale 9.684
Salva come PNG Salva come JPEG
Nome #
Inositolo e sindrome metabolica in menopausa 244
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 172
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 167
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 166
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 166
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 162
Italian risk factor-based screening for gestational diabetes. 150
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 149
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 144
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 143
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 141
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 139
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 137
Effects of myo-inositol on glucose variability in women with gestational diabetes 137
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 134
Myo-inositol may prevent gestational diabetes in PCOS women 131
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 131
Myo-inositol and melatonin in the menopausal transition 131
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 129
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 129
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 129
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 128
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 127
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 125
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 124
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 123
Cardiovascular effects of the phytoestrogen genistein 120
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 120
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 120
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 116
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 116
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 115
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 115
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 115
ADAM 12 come marker precoce di preeclampsia 114
C-reactive protein as an early predictor of gestational diabetes mellitus 113
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 113
Compliance with hormone replacement therapy in postmenopausal Sicilian women 112
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 112
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 112
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 111
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 111
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 110
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 110
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 109
Cardiovascular effects of raloxifene hydrochloride 109
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 108
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 108
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 108
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 107
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 107
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 107
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 107
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 106
Dietary management of skin health: The role of genistein 105
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 105
Midtrimester amniotic fluid adiponectin in normal pregnancy. 104
Maternal serum PAPP-A as an early marker of obstetric complications? 104
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 102
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 102
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 102
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 101
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 101
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 99
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 99
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 99
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 97
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 97
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 97
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 96
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 94
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 94
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 93
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 93
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 92
La disfunzione diastolica nel diabete gestazionale 92
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 91
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 90
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 90
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 90
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 89
Genistein aglycone use in metabolic syndrome: preliminary results from a randomized clinical trial in postmenopausal women 88
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 88
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 87
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 87
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 87
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 87
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 86
The impact of kidney development on the life course: a consensus document for action 86
THE PHYTOESTROGEN GENISTEIN PHYSIOLOGICALLY IMPROVES BONE AND CARDIOVASCULAR FUNCTIONALITY IN POSTMENOPAUSAL WOMEN 85
Inflammatory markers in women with a recent history of gestational diabetes mellitus 84
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 84
Genistein in the metabolic syndrome: results of a randomized clinical trial. 84
Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal 84
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 83
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 83
Pregnancy outcome following mid-trimester amniocentesis 82
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women 82
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials 82
Rupture of the cervix in a sulprostone induced abortion in the second trimester 81
Totale 11.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 0 0 120 90 128 73 138 79 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/20263.709 595 724 733 759 811 87 0 0 0 0 0 0
Totale 15.696